News and Views

New Research Opens the Door to ‘Functional Cure’ for HIV

Susana Valente led the research on new “Block-and-Lock” approach to stop virus.

‘Double Decker’ Antibody Technology Fights Cancer

Scientists in the Rader Lab advance strategy to target cancer without harming healthy cells.

Scientists Develop Broad-Spectrum Inhibitors of Influenza Viruses

Structural biology in the Wilson Lab shows that peptides can mimic antibodies to target the influenza virus.

Scripps Florida Scientists Share $9 Million Grant to Develop Therapies that Target the Aging Process

Paul Robbins to co-lead study of health seniors over age 100.

TSRI’s Benjamin Cravatt Elected to National Academy of Medicine

“Ben is a remarkable scientist whose discoveries have greatly expanded new opportunities for drug development,” said TSRI President and CEO Peter Schultz.

Gabriel Ozorowski Awarded Mathilde Krim Fellowship

Sandelman Travel Award Winners Announced

John Yates III and Gary Siuzdak Make The Analytical Scientist’s Top 10

Photos: 2017 DNC Neuroscience Symposium

TSRI Study Reveals New Clues to How a Successful HIV Vaccine Could Work
Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award
TSRI Scientist Wins Prestigious Young Investigator Award
TSRI Chemists Develop Inexpensive, Versatile Technique for Making RNA
TSRI Awarded $11 Million Grant Renewal by NIAID for Long-Running Study of Immunity, Inflammation
Protein Profiling Method Reveals Many Potential New Drug Targets
TSRI Ranks No. 1 in Innovation Influence
Scripps Florida Scientists Identify Protein Deficiency Involved in Childhood Anemia and Cancers
One Cytokine To Control Multiple Cytokines
NIH-supported scientists elicit broadly neutralizing antibodies to HIV in calves

SEARCH NEWS & VIEWS